Clinical Characteristics of Pregnancy-Associated Central Serous Chorioretinopathy in the Chinese Population

Table 1

Demographic characteristics and clinical data of Chinese patients with pregnancy-associated central serous chorioretinopathy.

Case

Age (years)

BP at initial visit (mmHg)

Number of the current pregnancy

History of CSC in the first pregnancy

Eye

Gestational week at onset of current CSC (weeks)

Duration of symptoms of CSC at initial visit (days)

BCVA at initial visit (Snellen)

Number of RPE abnormal sites on OCT

Treatment

Follow-up duration

BCVA at final visit (Snellen)

Subretinal fluid at final visit

EZ status at fovea at final visit

1

34

120/79

1

OD

31 + 2

5

20/100

1

N/A

N/A

N/A

N/A

N/A

2

33

116/73

1

OS

26

14

20/25

1

No

PPD 70 days

20/20

None

Intact

3

42

105/70

1

OD

27

28

20/50

mf

No

PPD 144 days

20/20

None

Intact

OS

27 + 2

26

20/50

mf

Half-dose PDT

PPD 56 months (after half-dose PDT 30 months)

20/50

None

Discontinuous

4

35

110/70

1

OD

29

30

20/60

mf

No

PPD 35 days

20/25

None

Intact

OS

29

30

20/60

mf

No

PPD 35 days

20/30

None

Intact

5

36

100/80

2

Yes

OD

27 + 5

2

20/30

mf

No

GW 35

20/20

None

Intact

6

34

110/70

2

No

OS

28

3

20/40

1

N/A

N/A

N/A

N/A

N/A

7

29

121/71

2

Yes

OD

25 + 4

38

20/25

1

No

PPD 6 weeks

20/20

None

Intact

8

40

116/66

1

OD

24 + 2

7

20/50

mf

N/A

N/A

N/A

N/A

N/A

9

32

120/80

2

No

OD

27 + 4

34

20/50

1

N/A

N/A

N/A

N/A

N/A

BCVA, best-corrected visual acuity; BP, blood pressure; CSC, central serous chorioretinopathy; EZ, ellipsoid zone; GW, gestational week; mf, multifocal; N/A, not applicable; OCT, optical coherence tomography; PDT, photodynamic therapy; PPD, postpartum day; Y, yes.